Page last updated: 2024-11-02

phenobarbital and Blepharoptosis

phenobarbital has been researched along with Blepharoptosis in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Subarnas, A1
Tadano, T1
Oshima, Y1
Kisara, K1
Ohizumi, Y1

Other Studies

1 other study available for phenobarbital and Blepharoptosis

ArticleYear
Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
    The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:6

    Topics: Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Catalepsy; Central Nervous System; Dose

1993